Luo Yuling 4

What Happened

• Luo Yuling, CEO of Alamar Biosciences (ALMR), converted several blocks of previously held convertible securities into common stock and received RSU awards. The filing shows multiple zero-dollar conversions and reclassifications of share classes on/around April 16–20, 2026, plus two RSU grants totaling 417,700 shares (341,191 on 4/16 and 76,509 on 4/20) issued at $0.00.
• The conversion/reclassification entries include large blocks reported in the filing (examples): 1,864,065; 1,386,746; 1,224,152; 1,033,912; and 364,268 shares, among other smaller blocks. Most conversions and related “other acquisition/disposition” entries were recorded at $0 (non-cash), reflecting conversion of convertible/preferred instruments and internal reclassification rather than an open-market buy or sale.

Key Details

• Transaction dates: primarily April 16, 2026 (RSU grant) and April 20, 2026 (conversions, reclassifications, RSU grant).
• Prices: All conversions and RSU grants reported at $0.00 (non-cash). No cash purchases or open-market sales reported.
• RSU totals: 341,191 RSUs granted 4/16/2026 and 76,509 RSUs granted 4/20/2026 = 417,700 RSUs awarded.
• Notable converted blocks (as reported): 1,864,065; 1,386,746; 1,224,152; 1,033,912; 364,268 shares (plus several smaller blocks).
• Footnotes: Conversions reflect automatic reclassification/conversion of Class A, Founders Preferred and Series A-1 Preferred into common stock prior to the IPO (see F1–F3). Several awards/options have time-based monthly vesting schedules (see F4, F5, F7–F11); some grants are fully vested per the filing (F6).
• Filing timeliness: filing dated April 20, 2026 for transactions reported 4/16–4/20; no late-filing flag noted in the provided data.

Context

• These entries are largely non-cash corporate actions (conversion/reclassification of convertible securities and issuance of RSUs) related to capital-structure changes around the IPO. They do not reflect an open-market purchase or sale that would indicate immediate bullish or bearish trading intent.
• For retail investors: conversions and zero-dollar RSU grants are routine following IPO-related restructurings and reflect internal ownership reclassification or compensation, not a cash investment or sale by the CEO.